Direct comparison of thallium-201 and technetium-99m MIBI SPECT of a glioma by receiver operating characteristic analysis

Journal of Clinical Neuroscience

Volumn 16, Issue 2, 2009, Pages 264-269

  Shibata, Y ^a   Yamamoto, T ^a   Takano, S ^a   Katayama, W ^a   Takeda, T ^a   Matsumura, A ^a  

^a University of Tsukuba   (Japan)

Author keywords

Glioma; Malignancy; Receiver operating characteristic; Single photon emission computed tomography; Tc MIBI; Thallium

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; GLIOMA; HUMAN; MALE; NEUROIMAGING; PRIORITY JOURNAL; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ROC CURVE; TECHNETIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 58149204031     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.04.010     Document Type: Article

References (39)

1. Black K.L., Hawkins R.A., Kim K.T., et al. Use of thallium-201 SPECT to quantitate the malignancy grade of gliomas. J Neurosurg 71 (1989) 342-346
2. Kosuda S., Shioyama Y., Kamata N., et al. [Differential diagnosis between recurrence of brain tumor and radiation necrosis by 201Tl SPECT]. Nippon Igaku Hoshasen Gakkai Zasshi 51 (1991) 415-421
3. Kosuda S., Fujii H., Aoki S., et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 7 (1993) 257-263
4. Kahn D., Follett K.A., Bushnell D.L., et al. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F- fluorodeoxyglucose PET. Am J Roentgenol 163 (1994) 1459-1465
5. Burkard R., Kaiser K.P., Wieler H., et al. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg Rev 15 (1992) 265-273
6. Staffen W., Hondl N., Trinka E., et al. Clinical relevance of 201Tl-chloride SPECT in the differential diagnosis of brain tumours. Nucl Med Commun 19 (1998) 335-340
7. Serizawa T., Saeki N., Higuchi Y., et al. Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 102 Suppl (2005) 266-271
8. Comte F., Bauchet L., Rigau V., et al. Correlation of preoperative thallium SPECT with histological grading and overall survival in adult gliomas. Nucl Med Commun 27 (2006) 137-142
9. Metz C.E. ROC methodology in radiologic imaging. Invest Radiol 21 (1986) 720-733
10. Metz CE, A. HB, Jong-Her S. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stats Med 1998;17:1033-1053.
11. O'Tuama L.A., Janicek M.J., Barnes P.D., et al. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol 7 (1991) 249-257
12. Yoshii Y., Satou M., Yamamoto T., et al. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20 (1993) 39-45
13. Schwartz R.B., Carvalho P.A., Alexander III E., et al. Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. AJNR Am J Neuroradiol 12 (1991) 1187-1192
14. Ueda T., Kaji Y., Wakisaka S., et al. Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 20 (1993) 138-145
15. Sugo N., Yokota K., Kondo K., et al. Early dynamic 201Tl SPECT in the evaluation of brain tumours. Nucl Med Commun 27 (2006) 143-149
16. Buchpiguel C.A., Alavi J.B., Alavi A., et al. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 36 (1995) 159-164
17. Rollins N.K., Lowry P.A., and Shapiro K.N. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 22 (1995) 8-14
18. Kallen K., Burtscher I.M., Holtas S., et al. 201-Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol 46 (2000) 173-185
19. Young R.J., Ghesani M.V., Kagetsu N.J., et al. Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients. AJNR Am J Neuroradiol 26 (2005) 1973-1979
20. Kumabe T., Shimizu H., Sonoda Y., et al. Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three technical case reports. Neurosurg 45 (1999) 183-187
21. Kanamori M., Kumabe T., Shimizu H., et al. (201)Tl-SPECT, (1)H-MRS, and MIB-1 labeling index of central neurocytomas: three case reports. Acta Neurochir (Wien) 144 (2002) 157-163
22. Soler C., Beauchesne P., Maatougui K., et al. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25 (1998) 1649-1657
23. Le Jeune F.P., Dubois F., Blond S., et al. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 77 (2006) 177-183
24. Ak I., Gulbas Z., Altinel F., et al. Tc-99m MIBI uptake and its relation to the proliferative potential of brain tumors. Clin Nucl Med 28 (2003) 29-33
25. Beauchesne P., and Soler C. Correlation of 99mTc-MIBI brain spect (functional index ratios) and survival after treatment failure in malignant glioma patients. Anticancer Res 22 (2002) 3081-3085
26. Beauchesne P., Pedeux R., Boniol M., et al. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med 45 (2004) 409-413
27. Yamamoto Y., Nishiyama Y., Toyama Y., et al. 99mTc-MIBI and 201Tl SPET in the detection of recurrent brain tumours after radiation therapy. Nucl Med Commun 23 (2002) 1183-1190
28. Baillet G., Albuquerque L., Chen Q., et al. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21 (1994) 1061-1066
29. Henze M., Mohammed A., Schlemmer H.P., et al. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis. J Nucl Med 45 (2004) 579-586
30. Kirton A., Kloiber R., Rigel J., et al. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT. J Nucl Med 43 (2002) 1438-1443
31. O'Tuama L.A., Treves S.T., Larar J.N., et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 34 (1993) 1045-1051
32. Nishiyama Y., Yamamoto Y., Fukunaga K., et al. Comparison of 99Tcm-MIBI with 201Tl chloride SPET in patients with malignant brain tumours. Nucl Med Commun 22 (2001) 631-639
33. Feun L.G., Savaraj N., and Landy H.J. Drug resistance in brain tumors. J Neurooncol 20 (1994) 165-176
34. Lehnert M. Multidrug resistance in human cancer. J Neurooncol 22 (1994) 239-243
35. Andrews D.W., Das R., Kim S., et al. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurg 40 (1997) 1323-1332
36. Ballinger J.R., Sheldon K.M., Boxen I., et al. Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein. Q J Nucl Med 39 (1995) 122-128
37. Piwnica-Worms D., Chiu M.L., Budding M., et al. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53 (1993) 977-984
38. Shibata Y., Matsumura A., and Nose T. Effect of expression of P-glycoprotein on technetium-99m methoxyisobutylisonitrile single photon emission computed tomography of brain tumors. Neurol Med Chir (Tokyo) 42 (2002) 325-330
39. Henze M., Mohammed A., Schlemmer H., et al. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl-L-tyrosine and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 29 (2002) 1455-1461